Elisete Isabel Crocco

Elisete Isabel Crocco

Auto-generated profile, based on publicly available information

Elisete Isabel Crocco

Faculty of Medical Sciences of Santa Casa de São Paulo , São Paulo

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2015 in Journal of Cosmetic and Laser Therapy
Verified
Journal Article
Closed access
PDF file
RARenata Oliveira Alves
Renata Oliveira Alves
MBMaria Fernanda Camargo Boin
Maria Fernanda Camargo Boin
ECElisete Isabel Crocco
Elisete Isabel Crocco
Striae distensae are atrophic dermal scars associated with psychosocial stress. Several treatments have been used but there is no gold standard until now. Fractional photothermolysis has been described as a successful and safe method to treat scars. In this description, we report 4 patients (Fitzpatrick phototype IV) who developed striae distensae after long-term use of topical corticosteroids and were successfully treated with fractional nonablative 1540 nm Erbium: glass laser.

1 August 2018 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
ECElisete Isabel Crocco
Elisete Isabel Crocco
GMGuilherme Muzy
Guilherme Muzy
NSNatalia M. Schowe
Natalia M. Schowe
MAMarilia S. Albuquerque
Marilia S. Albuquerque
MBMirna D. Barros
Mirna D. Barros
HBHudson S. Buck
Hudson S. Buck

20 May 2020 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
ECElisete Isabel Crocco
Elisete Isabel Crocco
EBEvellin Barbosa Bonifácio
Evellin Barbosa Bonifácio
Gustavo FacchiniGustavo Facchini
Gustavo Facchini
GSGustavo Henrique da Silva
Gustavo Henrique da Silva
MSMichelle Sabrina da Silva
Michelle Sabrina da Silva
SESamara Eberlin
Samara Eberlin

15 July 2025 in Dermatologic Surgery
Verified
Journal Article
Closed access
GOGisele Viana de Oliveira
Gisele Viana de Oliveira
ACAnnia Alves Rodrigues Cordeiro
Annia Alves Rodrigues Cordeiro
LPLuanna Caires Portela
Luanna Caires Portela
DHDoris Hexsel
Doris Hexsel
EPEliandre Palermo
Eliandre Palermo
ECElisete Isabel Crocco
Elisete Isabel Crocco
BACKGROUND: The illegal practice of medicine in aesthetic procedures poses significant public health risks because of complications from unqualified individuals. Invasive treatments such as botulinum toxin and fillers are frequently performed by nonmedical professionals without proper medical training, resulting in infections, necrosis, and lasting sequelae. OBJECTIVE: This study aimed to analyze the complications from nonphysicians encountered by Brazilian specialists (dermatologists, plastic surgeons, and other specialists) in their clinical practice. MATERIALS AND METHODS: A multicenter survey involving 1,058 physicians (primarily dermatologists and plastic surgeons) across Brazil assessed complications from aesthetic procedures performed by nonmedical individuals. Descriptive statistics categorized complications by type and severity, identified responsible practitioners, and estimated the health care and economic burdens. RESULTS: Over half of the respondents treat more than 100 patients monthly, and 12.69% of patients had undergone procedures by nonmedical professionals. On average, five complications were treated monthly per physician; 17% led to permanent sequelae. Common issues included scarring (78.68%), inflammation (72.15%), and infection (65.43%). Most cases required up to 3 specialists and 7 to 8 consultations per year, often involving multiple surgeries. CONCLUSION: These findings underscore the urgent need for regulatory enforcement, public education, and legal protection. Brazil's experience may inform other countries confronting similar issues related to the unauthorized practice of aesthetic medicine.

25 January 2016 in Journal of Cosmetic and Laser Therapy
Verified
Journal Article
Closed access
ECElisete Crocco
Elisete Crocco
MPMirella Pascini
Mirella Pascini
NSNathalie Suzuki
Nathalie Suzuki
RARenata Alves
Renata Alves
TPThais Proença
Thais Proença
RLRute Lellis
Rute Lellis
Silicone oil injections are often used for soft tissue augmentation and local and general adverse effects occurring from a few months to 15 years after injection have been reported. Here, we present a case of delayed granuloma formation due to liquid injectable silicone with large extent of involvement, which precluded surgical removal. Our patient was successfully treated with minocycline, considering its anti-inflammatory, immunomodulating and antigranulomatous properties. This case presents minocycline monotherapy as a useful treatment option for the management of severe granuloma induced by silicone use when surgical excision is not possible.

7 February 2024 in Journal of Cosmetic Dermatology
Verified
Journal Article
Open access
ECElisete Isabel Crocco
Elisete Isabel Crocco
LTLiliana Torloni
Liliana Torloni
PFPaula Bonilha Fernandes
Paula Bonilha Fernandes
MCMaria Elisa Barbosa Bueno de Campos
Maria Elisa Barbosa Bueno de Campos
MGMaura Gonzaga
Maura Gonzaga
VCVivienne Carduz Castilho
Vivienne Carduz Castilho
Background: Melasma is a chronic dermatosis that impacts the patient's quality of life and can present considerable challenges in terms of effective treatment. Objective: To evaluate the effectiveness, tolerability, and safety of 5% cysteamine combined with 4% nicotinamide in female subjects with melasma. Methods: This single‐center, single‐arm, prospective, open‐label study evaluated patients with melasma using a combination cream of 5% cysteamine and 4% nicotinamide in a progressive regimen (60 min in the first month, 120 min in the second month, and 180 min in the third month). Results: Overall, 35 treated subjects exhibited reduced modified Melasma Area and Severity Index (mMASI) ( p < 0.001) and decreased MelasQoL scores ( p < 0.001), accompanied by improved brightness, luminosity, homogeneity, and spot intensity ( p < 0.001). Photographic and colorimetric analysis revealed smaller spots and improved homogeneity. Limitations: Adherence to progressive daily treatment could not be evaluated long‐term. Conclusion: A combination cream comprising 5% cysteamine and 4% nicotinamide was effective, tolerable, and safe for treating melasma.